Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-004859

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
May 24, 2016
Accepted (ET)
Jun 6, 2016 · 6:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5May 24, 2016L1$6.51A40,779IBy: Separately Managed Account
Common StockF1,F5Jun 2, 2016P481$6.51A41,260IBy: Separately Managed Account
Common StockF1,F5Jun 3, 2016P9$6.51A41,269IBy: Separately Managed Account
Common StockF1,F5Jun 6, 2016P314$6.51A41,583IBy: Separately Managed Account
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses